WMS Partners’s Bio-Techne TECH Stock Holding History

WMS Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,484	Closed	-$269K	–	285
2022 Q1	$269K	Sell	2,484 -8,112	-77%	-$837K	0.04%	205
2021 Q4	$1.37M	Buy	10,596 +2,044	+24%	+$251K	0.29%	62
2021 Q3	$1.04M	Buy	8,552 +2,580	+43%	+$314K	0.15%	82
2021 Q2	$672K	Sell	5,972 -212	-3%	-$22.3K	0.1%	111
2021 Q1	$590K	Hold	6,184	–	–	0.13%	106
2020 Q4	$491K	Buy	6,184 +312	+5%	+$22.6K	0.08%	131
2020 Q3	$364K	Buy	5,872 +56	+1%	+$3.64K	0.07%	149
2020 Q2	$384K	Buy	5,816 +280	+5%	+$16.8K	0.08%	136
2020 Q1	$262K	Hold	5,536	–	–	0.07%	151
2019 Q4	$304K	Hold	5,536	–	–	0.07%	180
2019 Q3	$271K	Buy	5,536 +1,380	+33%	+$69.2K	0.07%	188
2019 Q2	$217K	Buy	+4,156	New	+$209K	0.05%	203
2016 Q3	–	Sell	-7,396	Closed	-$209K	–	208
2016 Q2	$209K	Buy	+7,396	New	+$190K	0.03%	197

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

WMS Partners's TECH Position: Q2 2022 in Review

WMS Partners sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 2,484 shares — an estimated $269K sold.

WMS Partners first reported a position in TECH in Q2 2016 and held it in 13 quarters. The position peaked at $1.37M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

WMS Partners reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
WMS Partners sold 2,484 Bio-Techne shares in Q2 2022, an estimated $269K.
WMS Partners first reported a position in Bio-Techne in Q2 2016 and held it in 13 quarters.
WMS Partners's Bio-Techne position peaked at $1.37M in Q4 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on WMS Partners's 13F filing for Q2 2022, filed 5 Aug 2022.